Toxicology Research Bulletin

The plethora of literature has supported the potential benefits of Resveratrol (RV) as a life- extending as well as an anticancer compound. However, these two functional discrepancies resulted at different concentration ranges. Likewise, the role of Resveratrol on adult neurogenesis still remains controversial and less understood despite its well documented health benefits.

Publication Type

Book Chapter

Experts

Jahan S, Khanna VK, Kumar D, Kumar V, Pandey A, Pant AB, Rajpurohit CS, Shukla RK, Singh S, Srivastava A, Yadav S

Time Frame

2016

Read More Category:

Description

The plethora of literature has supported the potential benefits of Resveratrol (RV) as a life- extending as well as an anticancer compound. However, these two functional discrepancies resulted at different concentration ranges. Likewise, the role of Resveratrol on adult neurogenesis still remains controversial and less understood despite its well documented health benefits. To gather insight into the biological effects of RV on neurogenesis, authors evaluated the possible effects of the compound on the proliferation and survival of neural progenitor cells (NPCs) in culture, and in the hippocampus of aged rats. Resveratrol exerted biphasic effects on NPCs; low concentrations (10 μM) stimulated cell proliferation mediated by increased phosphorylation of extracellular signal-regulated kinases (ERKs) and p38 kinases, whereas high concentrations (>20 μM) exhibited inhibitory effects. Administration of Resveratrol (20 mg/kg body weight) to adult rats significantly increased the number of newly generated cells in the hippocampus, with upregulation of p-CREB and SIRT1 proteins implicated in neuronal survival and lifespan extension respectively. Authors have successfully demonstrated that Resveratrol exhibits dose dependent discrepancies and at a lower concentration can have a positive impact on the proliferation, survival of NPCs and aged rat hippocampal neurogenesis implicating its potential as a candidate for restorative therapies against age related disorders.

Additional information

Publication Type

Book Chapter

Experts

Jahan S, Khanna VK, Kumar D, Kumar V, Pandey A, Pant AB, Rajpurohit CS, Shukla RK, Singh S, Srivastava A, Yadav S

Time Frame

2016